Half of asthma patients in the UK overusing SABAs, study finds In a UK asthma programme, 284,683 out of 574,913 patients were found to be “potentially overusing” short-acting β2-agonists.…
Top ten opinion pieces of 2020 Our news and views team has worked hard to keep you in the loop during a year full of twists and turns. And there’s been no shortage of COVID-19 developments for our opinion leaders to analyse, or pharmacy predictions to ponder.…
Chronic obstructive pulmonary disease: diagnosis and management Early diagnosis and medicines optimisation are fundamental to ensure timely and appropriate treatment of chronic obstructive pulmonary disease and improve a patient’s quality of life.…
Respiratory impairment persists for weeks post-discharge in hospitalised COVID-19 patients Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.…
Researchers to study whether vitamin D offers protection against COVID-19 Researchers at Queen Mary University of London have launched a clinical trial to investigate whether vitamin D can help protect against COVID-19.…
Personalised medicine approach could benefit people with asthma Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.…
Honey effective at relieving URTI symptoms, analysis concludes Honey is superior to usual care for improving symptoms of upper respiratory tract infection symptoms, researchers have concluded.…
Novel once-daily fixed-dose ICS–LABA improves lung function over ICS monotherapy, research finds A once-daily fixed-dose combination of inhaled corticosteroids and long-acting β2-adrenoceptor agonist significantly improved lung function over inhaled corticosteroids alone, a phase III study has concluded.…
Once-daily ICS-LABA-LAMA superior to ICS-LABA in improving lung function, research suggests A study in The Lancet Respiratory Medicine indicates that ICS-LABA-LAMA once daily is better than ICS-LABA in improving lung function.…
Delaying antibiotics in upper respiratory tract infection could increase risk of hospital admission, study suggests Delayed antibiotic prescribing is associated with an increase in the risk of infection-related hospital admissions and repeat antibiotic prescribing in patients with upper respiratory tract infection, a study in Clinical Infectious Diseases has suggested.…
